$7.81
-0.42-5.10%
At close: Jun 5, 5:00 PM EST
$7.81
N/A
After Hours: Jun 5, 4:00 PM EST
BridgeBio Oncology Therapeutics Inc Earnings Estimates
BBOTNASDAQ
BridgeBio Oncology Earnings Estimates, EPS & Revenue | NASDAQ:BBOT
BridgeBio Oncology (BBOT) is scheduled to report Q2 earnings on August 26, 2026. Analysts estimate EPS of $-0.54 and quarterly revenue of N/A.
In the most recent quarter (Q1), BridgeBio Oncology reported EPS of $-526.11, missing estimates of $-0.51 by 1030.59%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 3 quarters, BridgeBio Oncology has averaged an EPS surprise of 344.21% and a revenue surprise of 0.00%.
Earnings Date
Aug 26
EPS Estimate
$-0.540
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
BridgeBio Oncology Earnings History
Analyze the earnings history of BridgeBio Oncology using advanced sorting and filters.
Loading calendar...
BridgeBio Oncology (BBOT) Earnings Per Share
The chart below shows BridgeBio Oncology's reported EPS compared to analyst estimates over recent quarters.
BridgeBio Oncology (BBOT) Revenue
The chart below shows BridgeBio Oncology's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BridgeBio Oncology (NASDAQ:BBOT) reporting earnings?
BridgeBio Oncology (BBOT) is scheduled to report earnings on August 26, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for BridgeBio Oncology (NASDAQ:BBOT)?
The Actual EPS was $-526.11, which missed the estimate of $-0.51.
What were BridgeBio Oncology’s (NASDAQ:BBOT) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
